Cagliari, Italy

Luca Pani

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Luca Pani: Pioneering Advances in Opioidergic Compounds

Introduction: Luca Pani, an accomplished inventor based in Cagliari, Italy, has made significant contributions to the field of pharmaceutical chemistry. With three patents to her name, she focuses on the development of innovative compounds that target opioidergic receptors, which hold promise for pain management and therapeutic interventions.

Latest Patents: Luca Pani's most recent patents showcase her expertise in creating substituted diazabicyclo compounds. Her first patent details substituted 3,8-diazabicyclo[3.2.1]octane compounds with a specific affinity for delta opioidergic receptors, emphasizing both central and peripheral activity. The second patent explores nonane and decane diazabicyclic derivatives, which utilize homopiperazine as the main ring and demonstrate interaction with μ, δ, and κ receptors, along with their subclasses. These innovative formulations signal a promising future for pharmaceutical research in pain management.

Career Highlights: Throughout her career, Pani has been dedicated to advancing the study of opioidergic compounds. Her work at Neuroscienze Pharmaness S.c.a.r.l. underscores her commitment to developing effective pharmaceuticals that can alleviate pain and enhance patient outcomes. Her research reflects a deep understanding of receptor interactions and compound design, contributing valuable insights to the industry.

Collaborations: At Neuroscienze Pharmaness, Luca Pani collaborates with talented professionals like Paolo Lazzari and Giovanni Loriga. These partnerships enhance the innovative spirit of the organization and foster an environment conducive to groundbreaking research and development in pharmaceuticals.

Conclusion: Luca Pani stands out as a key figure in pharmaceutical innovation, driving advancements in the field of opioidergic compounds. Her patents reflect a dedication to improving therapeutic options and tackling significant challenges in pain management. As her research progresses, the implications of her work will likely resonate across the medical community, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…